Margien L. Seinen

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

Bindia Jharap, Margien L. Seinen, Nanne K.H. de Boer et al. · Inflammatory Bowel Diseases · 2010 · 198 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease

Frank Hoentjen, Margien L. Seinen, Stephen B. Hanauer et al. · Inflammatory Bowel Diseases · 2012 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practice.

Margien L. Seinen, Dirk P. van Asseldonk, Chris J. Mulder et al. · PubMed · 2010 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +14

The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: Results from a prospective pharmacological study

Margien L. Seinen, Dirk P. van Asseldonk, Nanne K.H. de Boer et al. · Journal of Crohn s and Colitis · 2013 · 48 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease

Margien L. Seinen, Cyriel Y. Ponsioen, Nanne K.H. de Boer et al. · Clinical Gastroenterology and Hepatology · 2013 · 43 citations

Pharmacy, Pharmacology, Pharmacotherapy +10